Qiagen NV Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Qiagen NV Stock Summary

Qiagen NV competes with Neogen, Aclaris Therapeutics, IQVIA Holdings, Medpace Holdings, and ICON PLC. QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. Qiagen NV operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 6200 people.

Qiagen NV Key Financial Ratios

Qiagen NV Key Balance Sheet Accounts

Qiagen NV Key Income Statement Accounts

Qiagen NV Key Cash Accounts

Qiagen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Qiagen NV's current stock value. Our valuation model uses many indicators to compare Qiagen NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Qiagen NV competition to find correlations between indicators driving Qiagen NV's intrinsic value. More Info.Qiagen NV is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers reporting about  2.33  of Return On Asset per Return On Equity. At this time, Qiagen NV's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Qiagen NV's earnings, one of the primary drivers of an investment's value.

Qiagen NV Systematic Risk

Today, most investors in Qiagen NV Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Qiagen NV's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Qiagen NV growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Qiagen NV help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Qiagen NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of Qiagen NV based on widely used predictive technical indicators. In general, we focus on analyzing Qiagen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Qiagen NV's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.